Specific interventions that bypass HLA-G mediated immune escape, e.g. blocking antibodies against the HLA-G isoforms upregulated in EwS, may substantially improve efficacy of cellular therapies in this and other cancers. This evidence concerns the gene HLA-G and cancer.